What medications are used to treat nightmares?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 24, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Medication for Nightmares

Prazosin remains the first-line pharmacological treatment for PTSD-associated nightmares despite recent conflicting evidence, while Image Rehearsal Therapy should be prioritized for all nightmare disorder patients. 1

First-Line Approach

  • Image Rehearsal Therapy (IRT) is the primary treatment for nightmare disorder, achieving 60-72% reduction in nightmare frequency and should be initiated before or alongside any medication. 1
  • For patients requiring pharmacological intervention, prazosin is the most established medication option. 2

Prazosin: The Primary Pharmacological Option

Dosing Strategy

  • Start at 1 mg at bedtime and titrate by 1-2 mg every few days until nightmares are controlled or side effects emerge. 2, 1
  • Average effective dose is approximately 3 mg for civilians, though military veterans with combat-related PTSD often require higher doses (9.5-13.3 mg/day). 2
  • Maximum recommended dose is 20 mg at bedtime. 3

Evidence Quality and Recent Controversy

  • The American Academy of Sleep Medicine initially gave prazosin Level A evidence based on three randomized controlled trials showing significant reduction in PTSD-associated nightmares. 2
  • However, a large 2018 VA study of 304 veterans found no benefit over placebo, leading to downgrading of the recommendation. 2
  • Despite this, the American Academy of Sleep Medicine acknowledges that many patients respond very well to prazosin in clinical practice, and it remains the first pharmacological choice. 2

Critical Drug Interaction

  • Concurrent use of SSRIs may reduce prazosin's effectiveness—one study showed 30.1-point CAPS reduction without SSRIs versus only 9.6 points with SSRIs. 2
  • Consider this interaction when selecting or combining treatments. 2

Monitoring Requirements

  • Monitor for orthostatic hypotension, especially after the first dose and with dose increases. 2, 1
  • Blood pressure checks are essential during titration. 1

Alternative Pharmacological Options

Topiramate (Second-Line for PTSD Nightmares)

  • Start at 12.5-25 mg daily and increase by 25-50 mg every 3-4 days. 2
  • Effective dose for 91% of responders is ≤100 mg/day, though range extends to 400 mg/day. 2
  • Achieved 79% reduction in nightmares with 50% complete suppression in one case series. 2
  • Significant side effects include urticaria, nausea, acute narrow-angle glaucoma, severe headaches, panic, suicidal ideation, and memory problems. 2

Trazodone (Consider for Comorbid Insomnia)

  • Dose range 25-600 mg (mean 212 mg) at bedtime. 2
  • Reduced nightmare frequency from 3.3 to 1.3 nights per week in 72% of veterans. 2
  • Major side effects: daytime sedation (most common), dizziness, headache, priapism (serious), orthostatic hypotension. 2, 1
  • 19% discontinuation rate due to adverse effects. 2

Nabilone (Synthetic Cannabinoid)

  • Start at 0.5 mg and titrate to maximum 3 mg based on efficacy and tolerability. 2
  • Reduced CAPS nightmare scores by 3.6 points versus 1.0 for placebo in military personnel. 2
  • 50% of patients were "much improved" versus 11% on placebo. 2
  • Side effects: dry mouth and headache most common. 2

Clonidine (Alternative Alpha-Agonist)

  • Dose 0.2-0.6 mg in divided doses. 1
  • Level C evidence for PTSD-associated nightmares. 1
  • Monitor blood pressure due to orthostatic hypotension risk. 1

Medications with Limited or Negative Evidence

Avoid or use with extreme caution:

  • Clonazepam and venlafaxine show no benefit over placebo for nightmare disorder. 1
  • Phenelzine (45-90 mg): eliminated nightmares in small case series but requires tyramine-restricted diet and has hypertensive crisis risk. 2
  • Benzodiazepines (triazolam 0.5 mg, nitrazepam 5 mg): reduced unpleasant dreams equally but only studied for 3 days. 2
  • Atypical antipsychotics (olanzapine, risperidone, aripiprazole): minimal evidence, reserve for refractory cases. 2

Critical Distinction: Night Terrors vs. Nightmares

  • Night terrors occur during deep non-REM sleep with complete amnesia, while nightmares occur during REM sleep with full recall. 4
  • Prazosin has NO role in night terrors—this is a common and dangerous prescribing error. 4
  • For night terrors, clonazepam is considered only when episodes are frequent, severe, or causing functional impairment. 4

Clinical Algorithm

  1. Initiate Image Rehearsal Therapy for all patients with nightmare disorder. 1

  2. For PTSD-associated nightmares requiring medication:

    • Start prazosin 1 mg at bedtime, titrate every few days. 2, 1
    • Check if patient is on SSRIs—consider alternative if so. 2
    • Monitor blood pressure. 1
  3. If prazosin fails or is not tolerated:

    • Consider topiramate (start 12.5-25 mg) if patient can tolerate cognitive side effects. 2
    • Consider trazodone (start 25-50 mg) if comorbid insomnia present. 2
    • Consider nabilone (start 0.5 mg) if available. 2
  4. For non-PTSD nightmare disorder:

    • Prazosin, nitrazepam, or triazolam may be used. 1
    • Behavioral therapy remains first-line. 1

Common Pitfalls

  • Do not confuse night terrors with nightmares—treatments differ completely. 4
  • Do not ignore SSRI interactions with prazosin—they may significantly reduce efficacy. 2
  • Do not use nefazodone as first-line due to hepatotoxicity risk. 2
  • Do not expect immediate results—therapeutic benefit may take up to one week. 5
  • Do not prescribe prazosin without blood pressure monitoring—orthostatic hypotension is the most common adverse effect. 2, 1

References

Guideline

Nightmare Disorder Treatment

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Treatment of Night Terrors

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Prazosin for treatment of nightmares related to posttraumatic stress disorder.

American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 2008

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.